跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用醋酸地加瑞克 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Degarelix Acetate for Injection
Approved
化学药品
Degarelix Acetate for Injection
Ferring Pharmaceuticals A/S
🇨🇳 National Medical Products Administration
Approval Date
Jul 24, 2019
Approval ID
7MaoULzlfdx
Company
Ferring Pharmaceuticals A/S
Type
化学药品
Approval Details
Approval Id
7MaoULzlfdx
Approval Number
H20180054
Generic Name
注射用醋酸地加瑞克
Generic Name En
Degarelix Acetate for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
80mg(按地加瑞克(C82H103N18O16Cl)计算)
Reg Date
2019-07-24
Expired Date
2024-07-23
Company Name
Ferring Pharmaceuticals A/S
Company Address
Amager Strandvej 405, 2770 Kastrup, Denmark
Production Company Name
Ferring GmbH
Production Company Address
Wittland 11, 24109 Kiel, Germany
Company Detail Path
/organization/ferring-pharmaceuticals-a-s
Production Company Detail Path
/organization/ferring-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 24, 2019
Approval ID
7MaoULzlfdx
Type
化学药品
Back to NMPA Approvals